Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J. Tuszynski MH, et al. Nat Med. 2005 May;11(5):551-5. doi: 10.1038/nm1239. Epub 2005 Apr 24. Nat Med. 2005. PMID: 15852017 Clinical Trial.
Growth factor gene therapy for Alzheimer disease.
Tuszynski MH, U HS, Alksne J, Bakay RA, Pay MM, Merrill D, Thal LJ. Tuszynski MH, et al. Among authors: pay mm. Neurosurg Focus. 2002 Nov 15;13(5):e5. doi: 10.3171/foc.2002.13.5.6. Neurosurg Focus. 2002. PMID: 15769074 Review.
Nerve growth factor gene therapy for Alzheimer's disease.
Tuszynski MH, Thal L, U HS, Pay MM, Blesch A, Conner J, Vahlsing HL. Tuszynski MH, et al. Among authors: pay mm. J Mol Neurosci. 2002 Aug-Oct;19(1-2):207. doi: 10.1007/s12031-002-0034-2. J Mol Neurosci. 2002. PMID: 12212782 Clinical Trial. No abstract available.
19 results